Status:
COMPLETED
Improving TB Diagnosis and Treatment Through Basic, Applied and Health Systems Research
Lead Sponsor:
University of Stellenbosch
Conditions:
Tuberculosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
TB is a global health problem and in South Africa rates as the second most important problem in terms of Burden of Disease. There are many reasons for this, among which are diagnostic difficulties, ex...
Detailed Description
In 2015, the World Health Organization (WHO) estimated that there were there were an estimated 10.4 million new TB cases, 1.8 million deaths, and 580 000 cases of drug-resistant TB with 1.4 million de...
Eligibility Criteria
Inclusion
- The patient is willing to provide specimens (urine, blood, stool, respiratory tract specimens and swabs)
- The patient is clinically suspected of having TB (Two WHO TB symptoms for HIV negative patients and one WHO TB symptom if HIV positive)
Exclusion
- The patient is under the age of 18 years old
- The patient declines consent
- The patient has too few clinical symptoms for TB
Key Trial Info
Start Date :
February 6 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
1549 Patients enrolled
Trial Details
Trial ID
NCT03356925
Start Date
February 6 2018
End Date
June 30 2022
Last Update
November 2 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Scottsdene Clinic
Cape Town, Western Cape, South Africa, 7570
2
Wallacedene Clinic
Cape Town, Western Cape, South Africa, 7570